The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
CHA-Global Market Insights and Sales Trends 2025
Synopsis
The global CHA market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of CHA in various end use industries. The expanding demands from the Cosmetics Additives and Pharmaceutical Intermediates, are propelling CHA market. Cosmetics Grade, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Pharmaceutical Grade segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for CHA market, driven by demand from China, the second largest economy with some signs of stabilising, the CHA market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for CHA, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global CHA market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global CHA market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, CHA sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of CHA covered in this report include Carbone scientific, Ark Pharm, Hangzhou Lingeba Technology, TCI, Wuhan 3B Scientific Corporation, HBCChem, Sichuan Nanbu Honest and Creditable Science-tech Ltd, BePharm Ltd and Yolne reagent, etc.
The global CHA market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Carbone scientific
Ark Pharm
Hangzhou Lingeba Technology
TCI
Wuhan 3B Scientific Corporation
HBCChem
Sichuan Nanbu Honest and Creditable Science-tech Ltd
BePharm Ltd
Yolne reagent
Aladdin
Hunan Hecheng
Beijing Yunbang Biosciences
Inolex
9Dingchem
Chen Hson Holding Limited
Yancheng Langde Chemical & Pharmaceutical
Global CHA market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global CHA market, Segment by Type:
Cosmetics Grade
Pharmaceutical Grade
Global CHA market, by Application
Cosmetics Additives
Pharmaceutical Intermediates
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of CHA manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of CHA in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
The global CHA market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of CHA in various end use industries. The expanding demands from the Cosmetics Additives and Pharmaceutical Intermediates, are propelling CHA market. Cosmetics Grade, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Pharmaceutical Grade segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for CHA market, driven by demand from China, the second largest economy with some signs of stabilising, the CHA market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for CHA, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global CHA market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global CHA market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, CHA sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of CHA covered in this report include Carbone scientific, Ark Pharm, Hangzhou Lingeba Technology, TCI, Wuhan 3B Scientific Corporation, HBCChem, Sichuan Nanbu Honest and Creditable Science-tech Ltd, BePharm Ltd and Yolne reagent, etc.
The global CHA market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Carbone scientific
Ark Pharm
Hangzhou Lingeba Technology
TCI
Wuhan 3B Scientific Corporation
HBCChem
Sichuan Nanbu Honest and Creditable Science-tech Ltd
BePharm Ltd
Yolne reagent
Aladdin
Hunan Hecheng
Beijing Yunbang Biosciences
Inolex
9Dingchem
Chen Hson Holding Limited
Yancheng Langde Chemical & Pharmaceutical
Global CHA market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global CHA market, Segment by Type:
Cosmetics Grade
Pharmaceutical Grade
Global CHA market, by Application
Cosmetics Additives
Pharmaceutical Intermediates
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of CHA manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of CHA in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 CHA Market Overview
1.1 CHA Product Overview
1.2 CHA Market Segment by Type
1.2.1 Cosmetics Grade
1.2.2 Pharmaceutical Grade
1.3 Global CHA Market Size by Type
1.3.1 Global CHA Market Size Overview by Type (2018-2029)
1.3.2 Global CHA Historic Market Size Review by Type (2018-2023)
1.3.3 Global CHA Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America CHA Sales Breakdown by Type (2018-2023)
1.4.2 Europe CHA Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific CHA Sales Breakdown by Type (2018-2023)
1.4.4 Latin America CHA Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa CHA Sales Breakdown by Type (2018-2023)
2 Global CHA Market Competition by Company
2.1 Global Top Players by CHA Sales (2018-2023)
2.2 Global Top Players by CHA Revenue (2018-2023)
2.3 Global Top Players by CHA Price (2018-2023)
2.4 Global Top Manufacturers CHA Manufacturing Base Distribution, Sales Area, Product Type
2.5 CHA Market Competitive Situation and Trends
2.5.1 CHA Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by CHA Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in CHA as of 2022)
2.7 Date of Key Manufacturers Enter into CHA Market
2.8 Key Manufacturers CHA Product Offered
2.9 Mergers & Acquisitions, Expansion
3 CHA Status and Outlook by Region
3.1 Global CHA Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global CHA Historic Market Size by Region
3.2.1 Global CHA Sales in Volume by Region (2018-2023)
3.2.2 Global CHA Sales in Value by Region (2018-2023)
3.2.3 Global CHA Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global CHA Forecasted Market Size by Region
3.3.1 Global CHA Sales in Volume by Region (2024-2029)
3.3.2 Global CHA Sales in Value by Region (2024-2029)
3.3.3 Global CHA Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global CHA by Application
4.1 CHA Market Segment by Application
4.1.1 Cosmetics Additives
4.1.2 Pharmaceutical Intermediates
4.2 Global CHA Market Size by Application
4.2.1 Global CHA Market Size Overview by Application (2018-2029)
4.2.2 Global CHA Historic Market Size Review by Application (2018-2023)
4.2.3 Global CHA Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America CHA Sales Breakdown by Application (2018-2023)
4.3.2 Europe CHA Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific CHA Sales Breakdown by Application (2018-2023)
4.3.4 Latin America CHA Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa CHA Sales Breakdown by Application (2018-2023)
5 North America CHA by Country
5.1 North America CHA Historic Market Size by Country
5.1.1 North America CHA Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America CHA Sales in Volume by Country (2018-2023)
5.1.3 North America CHA Sales in Value by Country (2018-2023)
5.2 North America CHA Forecasted Market Size by Country
5.2.1 North America CHA Sales in Volume by Country (2024-2029)
5.2.2 North America CHA Sales in Value by Country (2024-2029)
6 Europe CHA by Country
6.1 Europe CHA Historic Market Size by Country
6.1.1 Europe CHA Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe CHA Sales in Volume by Country (2018-2023)
6.1.3 Europe CHA Sales in Value by Country (2018-2023)
6.2 Europe CHA Forecasted Market Size by Country
6.2.1 Europe CHA Sales in Volume by Country (2024-2029)
6.2.2 Europe CHA Sales in Value by Country (2024-2029)
7 Asia-Pacific CHA by Region
7.1 Asia-Pacific CHA Historic Market Size by Region
7.1.1 Asia-Pacific CHA Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific CHA Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific CHA Sales in Value by Region (2018-2023)
7.2 Asia-Pacific CHA Forecasted Market Size by Region
7.2.1 Asia-Pacific CHA Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific CHA Sales in Value by Region (2024-2029)
8 Latin America CHA by Country
8.1 Latin America CHA Historic Market Size by Country
8.1.1 Latin America CHA Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America CHA Sales in Volume by Country (2018-2023)
8.1.3 Latin America CHA Sales in Value by Country (2018-2023)
8.2 Latin America CHA Forecasted Market Size by Country
8.2.1 Latin America CHA Sales in Volume by Country (2024-2029)
8.2.2 Latin America CHA Sales in Value by Country (2024-2029)
9 Middle East and Africa CHA by Country
9.1 Middle East and Africa CHA Historic Market Size by Country
9.1.1 Middle East and Africa CHA Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa CHA Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa CHA Sales in Value by Country (2018-2023)
9.2 Middle East and Africa CHA Forecasted Market Size by Country
9.2.1 Middle East and Africa CHA Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa CHA Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Carbone scientific
10.1.1 Carbone scientific Company Information
10.1.2 Carbone scientific Introduction and Business Overview
10.1.3 Carbone scientific CHA Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Carbone scientific CHA Products Offered
10.1.5 Carbone scientific Recent Development
10.2 Ark Pharm
10.2.1 Ark Pharm Company Information
10.2.2 Ark Pharm Introduction and Business Overview
10.2.3 Ark Pharm CHA Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Ark Pharm CHA Products Offered
10.2.5 Ark Pharm Recent Development
10.3 Hangzhou Lingeba Technology
10.3.1 Hangzhou Lingeba Technology Company Information
10.3.2 Hangzhou Lingeba Technology Introduction and Business Overview
10.3.3 Hangzhou Lingeba Technology CHA Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Hangzhou Lingeba Technology CHA Products Offered
10.3.5 Hangzhou Lingeba Technology Recent Development
10.4 TCI
10.4.1 TCI Company Information
10.4.2 TCI Introduction and Business Overview
10.4.3 TCI CHA Sales, Revenue and Gross Margin (2018-2023)
10.4.4 TCI CHA Products Offered
10.4.5 TCI Recent Development
10.5 Wuhan 3B Scientific Corporation
10.5.1 Wuhan 3B Scientific Corporation Company Information
10.5.2 Wuhan 3B Scientific Corporation Introduction and Business Overview
10.5.3 Wuhan 3B Scientific Corporation CHA Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Wuhan 3B Scientific Corporation CHA Products Offered
10.5.5 Wuhan 3B Scientific Corporation Recent Development
10.6 HBCChem
10.6.1 HBCChem Company Information
10.6.2 HBCChem Introduction and Business Overview
10.6.3 HBCChem CHA Sales, Revenue and Gross Margin (2018-2023)
10.6.4 HBCChem CHA Products Offered
10.6.5 HBCChem Recent Development
10.7 Sichuan Nanbu Honest and Creditable Science-tech Ltd
10.7.1 Sichuan Nanbu Honest and Creditable Science-tech Ltd Company Information
10.7.2 Sichuan Nanbu Honest and Creditable Science-tech Ltd Introduction and Business Overview
10.7.3 Sichuan Nanbu Honest and Creditable Science-tech Ltd CHA Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Sichuan Nanbu Honest and Creditable Science-tech Ltd CHA Products Offered
10.7.5 Sichuan Nanbu Honest and Creditable Science-tech Ltd Recent Development
10.8 BePharm Ltd
10.8.1 BePharm Ltd Company Information
10.8.2 BePharm Ltd Introduction and Business Overview
10.8.3 BePharm Ltd CHA Sales, Revenue and Gross Margin (2018-2023)
10.8.4 BePharm Ltd CHA Products Offered
10.8.5 BePharm Ltd Recent Development
10.9 Yolne reagent
10.9.1 Yolne reagent Company Information
10.9.2 Yolne reagent Introduction and Business Overview
10.9.3 Yolne reagent CHA Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Yolne reagent CHA Products Offered
10.9.5 Yolne reagent Recent Development
10.10 Aladdin
10.10.1 Aladdin Company Information
10.10.2 Aladdin Introduction and Business Overview
10.10.3 Aladdin CHA Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Aladdin CHA Products Offered
10.10.5 Aladdin Recent Development
10.11 Hunan Hecheng
10.11.1 Hunan Hecheng Company Information
10.11.2 Hunan Hecheng Introduction and Business Overview
10.11.3 Hunan Hecheng CHA Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Hunan Hecheng CHA Products Offered
10.11.5 Hunan Hecheng Recent Development
10.12 Beijing Yunbang Biosciences
10.12.1 Beijing Yunbang Biosciences Company Information
10.12.2 Beijing Yunbang Biosciences Introduction and Business Overview
10.12.3 Beijing Yunbang Biosciences CHA Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Beijing Yunbang Biosciences CHA Products Offered
10.12.5 Beijing Yunbang Biosciences Recent Development
10.13 Inolex
10.13.1 Inolex Company Information
10.13.2 Inolex Introduction and Business Overview
10.13.3 Inolex CHA Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Inolex CHA Products Offered
10.13.5 Inolex Recent Development
10.14 9Dingchem
10.14.1 9Dingchem Company Information
10.14.2 9Dingchem Introduction and Business Overview
10.14.3 9Dingchem CHA Sales, Revenue and Gross Margin (2018-2023)
10.14.4 9Dingchem CHA Products Offered
10.14.5 9Dingchem Recent Development
10.15 Chen Hson Holding Limited
10.15.1 Chen Hson Holding Limited Company Information
10.15.2 Chen Hson Holding Limited Introduction and Business Overview
10.15.3 Chen Hson Holding Limited CHA Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Chen Hson Holding Limited CHA Products Offered
10.15.5 Chen Hson Holding Limited Recent Development
10.16 Yancheng Langde Chemical & Pharmaceutical
10.16.1 Yancheng Langde Chemical & Pharmaceutical Company Information
10.16.2 Yancheng Langde Chemical & Pharmaceutical Introduction and Business Overview
10.16.3 Yancheng Langde Chemical & Pharmaceutical CHA Sales, Revenue and Gross Margin (2018-2023)
10.16.4 Yancheng Langde Chemical & Pharmaceutical CHA Products Offered
10.16.5 Yancheng Langde Chemical & Pharmaceutical Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 CHA Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 CHA Industrial Chain Analysis
11.4 CHA Market Dynamics
11.4.1 CHA Industry Trends
11.4.2 CHA Market Drivers
11.4.3 CHA Market Challenges
11.4.4 CHA Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 CHA Distributors
12.3 CHA Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
